Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsSecurities - TradableShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Praxis Precision Medicines (PRAX) Non-Current Deffered Revenue: 2022-2023

Historic Non-Current Deffered Revenue for Praxis Precision Medicines (PRAX) over the last 2 years, with Dec 2023 value amounting to $1.2 million.

  • Praxis Precision Medicines' Non-Current Deffered Revenue fell 80.67% to $293,000 in Q3 2024 from the same period last year, while for Sep 2024 it was $293,000, marking a year-over-year decrease of 80.67%. This contributed to the annual value of $1.2 million for FY2023, which is 46.79% down from last year.
  • According to the latest figures from FY2023, Praxis Precision Medicines' Non-Current Deffered Revenue is $1.2 million, which was down 46.79% from $2.2 million recorded in FY2022.
  • In the past 5 years, Praxis Precision Medicines' Non-Current Deffered Revenue ranged from a high of $2.2 million in FY2022 and a low of $1.2 million during FY2023.
  • Moreover, its 2-year median value for Non-Current Deffered Revenue was $1.7 million (2022), whereas its average is $1.7 million.
  • Data for Praxis Precision Medicines' Non-Current Deffered Revenue shows a maximum YoY crashed of 46.79% (in 2023) over the last 5 years.
  • Yearly analysis of 2 years shows Praxis Precision Medicines' Non-Current Deffered Revenue stood at $2.2 million in 2022, then slumped by 46.79% to $1.2 million in 2023.